<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Narayanapillai SC</submitter><funding>NCI NIH HHS</funding><pagination>2365-72</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4178470</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(10)</volume><pubmed_abstract>We have previously shown that kava and its flavokavain-free Fraction B completely blocked 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice with a preferential reduction in NNK-induced O (6)-methylguanine (O (6)-mG). In this study, we first identified natural (+)-dihydromethysticin (DHM) as a lead compound through evaluating the in vivo efficacy of five major compounds in Fraction B on reducing O (6)-mG in lung tissues. (+)-DHM demonstrated outstanding chemopreventive activity against NNK-induced lung tumorigenesis in A/J mice with 97% reduction of adenoma multiplicity at a dose of 0.05mg/g of diet (50 ppm). Synthetic (±)-DHM was equally effective as the natural (+)-DHM in these bioassays while a structurally similar analog, (+)-dihydrokavain (DHK)</pubmed_abstract><journal>Carcinogenesis</journal><pubmed_title>Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice.</pubmed_title><pmcid>PMC4178470</pmcid><funding_grant_id>R01 CA193278</funding_grant_id><funding_grant_id>P01 CA138338</funding_grant_id><funding_grant_id>P30 CA077598</funding_grant_id><funding_grant_id>R01 CA142649</funding_grant_id><funding_grant_id>R01 CA81301</funding_grant_id><pubmed_authors>O'Sullivan MG</pubmed_authors><pubmed_authors>Peterson LA</pubmed_authors><pubmed_authors>Hecht SS</pubmed_authors><pubmed_authors>Zhou B</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Xing C</pubmed_authors><pubmed_authors>Narayanapillai SC</pubmed_authors><pubmed_authors>Shaik AA</pubmed_authors><pubmed_authors>Balbo S</pubmed_authors><pubmed_authors>Leitzman P</pubmed_authors><pubmed_authors>Grill AE</pubmed_authors><pubmed_authors>Upadhyaya P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice.</name><description>We have previously shown that kava and its flavokavain-free Fraction B completely blocked 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice with a preferential reduction in NNK-induced O (6)-methylguanine (O (6)-mG). In this study, we first identified natural (+)-dihydromethysticin (DHM) as a lead compound through evaluating the in vivo efficacy of five major compounds in Fraction B on reducing O (6)-mG in lung tissues. (+)-DHM demonstrated outstanding chemopreventive activity against NNK-induced lung tumorigenesis in A/J mice with 97% reduction of adenoma multiplicity at a dose of 0.05mg/g of diet (50 ppm). Synthetic (±)-DHM was equally effective as the natural (+)-DHM in these bioassays while a structurally similar analog, (+)-dihydrokavain (DHK)</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Oct</publication><modification>2025-04-22T20:38:49.621Z</modification><creation>2019-03-27T01:36:40Z</creation></dates><accession>S-EPMC4178470</accession><cross_references><pubmed>25053626</pubmed><doi>10.1093/carcin/bgu149</doi></cross_references></HashMap>